S
Stephen V. Faraone
Researcher at State University of New York Upstate Medical University
Publications - 1470
Citations - 155368
Stephen V. Faraone is an academic researcher from State University of New York Upstate Medical University. The author has contributed to research in topics: Attention deficit hyperactivity disorder & Bipolar disorder. The author has an hindex of 188, co-authored 1427 publications receiving 140298 citations. Previous affiliations of Stephen V. Faraone include University of Bergen & National Institute for Health Research.
Papers
More filters
Journal ArticleDOI
Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3.
Stephen V. Faraone,Hai-Gwo Hwu,Chih-Min Liu,Wei J. Chen,M.T. Tsuang,Shih-Kai Liu,Ming-Hsien Shieh,Tzung-Jeng Hwang,Wen-Chen Ou-Yang,Chun-Ying Chen,Chwen-Cheng Chen,Jin-Jia Lin,Frank Huang-Chih Chou,Ching-Mo Chueh,Wei-Ming Liu,Mei-Hua Hall,Jessica Su,Paul Van Eerdewegh,Ming T. Tsuang +18 more
TL;DR: Genome-wide linkage analyses of schizophrenia have identified several regions that may harbor schizophrenia susceptibility genes, but given the complex etiology of the disorder, it is unlikely that all susceptibility regions have been detected.
Journal ArticleDOI
Physical Health, Media Use, and Mental Health in Children and Adolescents With ADHD During the COVID-19 Pandemic in Australia.
Emma Sciberras,Emma Sciberras,Pooja Patel,Mark A. Stokes,David Coghill,David Coghill,Christel M. Middeldorp,Mark A. Bellgrove,Stephen P. Becker,Stephen P. Becker,Daryl Efron,Daryl Efron,Argyris Stringaris,Stephen V. Faraone,Susannah T. Bellows,Jon Quach,Tobias Banaschewski,Jane McGillivray,Delyse Hutchinson,Timothy J. Silk,Timothy J. Silk,Glenn A. Melvin,Amanda G. Wood,Amanda G. Wood,Anna Jackson,George Loram,Lidia Engel,Alicia Montgomery,Elizabeth M. Westrupp,Elizabeth M. Westrupp,Elizabeth M. Westrupp +30 more
TL;DR: Child stress about COVID-19 restrictions was associated with poorer functioning across most domains and most parents reported positive changes for their child including more family time.
Journal ArticleDOI
Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder
Ivonne Jarick,Anna-Lena Volckmar,Carolin Pütter,Sonali Pechlivanis,T. T. Nguyen,Maria R. Dauvermann,Sebastian Beck,Özgür Albayrak,Susann Scherag,Susanne Gilsbach,Sven Cichon,Per Hoffmann,Franziska Degenhardt,Markus M. Nöthen,Stefan Schreiber,H-Erich Wichmann,Karl-Heinz Jöckel,Joachim Heinrich,Carla M. T. Tiesler,Stephen V. Faraone,Susanne Walitza,Judith Sinzig,Christine M. Freitag,Jobst Meyer,Beate Herpertz-Dahlmann,Gerd Lehmkuhl,Tobias J. Renner,Andreas Warnke,Marcel Romanos,Klaus-Peter Lesch,Andreas Reif,Benno G. Schimmelmann,Johannes Hebebrand,André Scherag,Anke Hinney +34 more
TL;DR: The results suggest that copy number variants at the parkinson protein 2 gene (PARK2) contribute to the genetic susceptibility of ADHD.
Journal ArticleDOI
Association between alpha-2a-adrenergic receptor gene and ADHD inattentive type.
Marcelo Schmitz,Daniel Denardin,Tatiana Laufer da Silva,Thiago Gatti Pianca,Tatiana Roman,Mara H. Hutz,Stephen V. Faraone,Luis Augusto Rohde +7 more
TL;DR: The results suggest that the ADRA2A may be associated with ADHD-I, replicating previous findings from clinical samples that have suggested the importance of this gene for the dimension of inattention, and support the role of the noradrenergic system in ADHD.
Journal ArticleDOI
Stimulant treatment for attention-deficit hyperactivity disorder and risk of developing substance use disorder
Annabeth P. Groenman,Jaap Oosterlaan,Nanda Rommelse,Barbara Franke,Corina U. Greven,Corina U. Greven,Pieter J. Hoekstra,Catharina A. Hartman,Marjolein Luman,Herbert Roeyers,Robert D. Oades,Joseph A. Sergeant,Jan K. Buitelaar,Stephen V. Faraone +13 more
TL;DR: Stimulant treatment appears to lower the risk of developing substance use disorders and does not have an impact on the development of nicotine dependence in adolescents with ADHD.